Tech Company Financing Transactions
ProCertus BioPharm Funding Round
ProCertus BioPharm, based in Madison, secured $2.2 million from Novartis Venture Fund and Venture Investors.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$2,230,000
Round
Undisclosed
Investors
Novartis Venture Fund (Campbell Murray)
Venture Investors (George Arida)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
510 Charmany Dr. 175 B
Madison, WI 53719
USA
Madison, WI 53719
USA
Phone
Website
Email Address
Overview
ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Weiss
Chief Scientific Officer
William Fahl
VP - Finance
Todd Argall
Browse more venture capital transactions:
Prev: 12/31/2009: HyPerformix venture capital transaction
Next: 12/31/2009: buySAFE venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs